Fidessa adds OTC equity derivatives to buy-side suite

Fidessa LatentZero, a provider of front-office solutions to the buy-side, has expanded the instrument coverage for its Capstone suite of products to include equity over-the-counter (OTC) derivatives.
By None

Fidessa LatentZero, a provider of front-office solutions to the buy-side, has expanded the instrument coverage for its Capstone suite of products to include equity over-the-counter (OTC) derivatives.

Capstone comprises the Minerva order and execution management system, the Sentinel pre- and post-trade compliance solution and the Tesseract portfolio modelling and decision support tool.

As a result of the expansion, institutional asset mangers that use Capstone will be able to model and manage OTC equity options, equity swaps, total return equity swaps and dynamic equity baskets alongside more traditional asset classes in a single, integrated environment.

According to Fidessa, these new contracts will offer clients greater choice and flexibility over the strategies they use, including 130/30 funds, which can be traded using dynamic equity baskets. The addition of equity OTC derivatives takes the number of derivative contracts handled by Capstone to 30 and gives users complete coverage of fixed income, foreign exchange, equities, commodities and commodity indices.

“We have worked very closely with our clients to enhance our derivatives trading capabilities and give them the greatest possible coverage across all asset classes, currencies and strategies,” said Peter John, derivatives product manager at Fidessa LatentZero, in a statement. “Derivatives are integrated across our entire product suite, and, in particular, closer integration with Tesseract and our compliance engine Sentinel have enhanced their functionality even further.”

To ensure regulatory compliance, Capstone users will be tightly integrated with Sentinel. Clients will also be able to source data from a number of derivatives pricing sources.

«